Taiwanese research unit, Merck team up on new drug development

Taiwan's Industrial Technology Research Institute (ITRI) signed a memorandum of understanding (MOU) with German pharmaceutical and life science giant Merck on Monday on cooperation to developed advanced biopharma technologies.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)